Biolidics Ltd
SGX:8YY
Biolidics Ltd
SGX:8YY
Price:
0.05
SGD
16.28%
Market Cap:
S$86.7m
Cash Flow Statement
Cash Flow Statement
Biolidics Ltd
Biolidics Ltd
Currency: SGD
| Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
(6)
|
(5)
|
(5)
|
(3)
|
(5)
|
(8)
|
(6)
|
(5)
|
(6)
|
(10)
|
(10)
|
(8)
|
(8)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Depreciation & Amortization |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
1
|
0
|
0
|
0
|
2
|
3
|
1
|
0
|
0
|
6
|
6
|
6
|
6
|
0
|
0
|
0
|
0
|
1
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
(1)
|
(0)
|
(3)
|
(1)
|
2
|
(1)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
1
|
0
|
0
|
|
| Cash from Operating Activities |
(5)
N/A
|
(5)
-11%
|
(5)
+12%
|
(5)
-16%
|
(2)
+54%
|
(2)
+24%
|
(5)
-149%
|
(4)
+8%
|
(5)
-10%
|
(3)
+34%
|
(3)
-10%
|
(2)
+38%
|
(2)
-2%
|
(2)
+8%
|
(2)
-16%
|
(1)
+41%
|
(2)
-50%
|
(2)
-14%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(3)
|
(2)
|
(2)
|
(2)
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-64%
|
(1)
-100%
|
(1)
-21%
|
(1)
+34%
|
(0)
+40%
|
(1)
-166%
|
(1)
+9%
|
(1)
-3%
|
0
N/A
|
(1)
N/A
|
(0)
+9%
|
(0)
+5%
|
(3)
-468%
|
(2)
+20%
|
(2)
N/A
|
(2)
N/A
|
(0)
+100%
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
(0)
|
(0)
|
0
|
3
|
3
|
0
|
0
|
0
|
0
|
6
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
3
|
|
| Net Issuance of Debt |
(0)
|
0
|
(0)
|
3
|
4
|
1
|
(1)
|
(1)
|
(2)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
|
| Other |
14
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
14
N/A
|
14
+0%
|
(0)
N/A
|
6
N/A
|
7
+33%
|
1
-85%
|
(1)
N/A
|
(1)
-13%
|
(2)
-25%
|
4
N/A
|
4
-8%
|
4
+8%
|
4
0%
|
(0)
N/A
|
1
N/A
|
1
+3%
|
2
+198%
|
2
+5%
|
|
| Change in Cash | |||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
9
N/A
|
8
-7%
|
(5)
N/A
|
(0)
+93%
|
5
N/A
|
(1)
N/A
|
(7)
-562%
|
(6)
+5%
|
(7)
-12%
|
1
N/A
|
(0)
N/A
|
2
N/A
|
1
-3%
|
(5)
N/A
|
(4)
+26%
|
(3)
+26%
|
(2)
+31%
|
0
N/A
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
(5)
N/A
|
(6)
-13%
|
(5)
+5%
|
(6)
-15%
|
(3)
+52%
|
(2)
+24%
|
(5)
-138%
|
(5)
+9%
|
(5)
-9%
|
(3)
+39%
|
(3)
-10%
|
(2)
+39%
|
(2)
-1%
|
(2)
+8%
|
(2)
-16%
|
(1)
+41%
|
(2)
-50%
|
(2)
-14%
|
|
Switch to:
Switch to:
See Also
Discover More
